Imago BioSciences Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Imago BioSciences's earnings have been declining at an average annual rate of -57.6%, while the Biotechs industry saw earnings growing at 17.4% annually.
Belangrijke informatie
-57.6%
Groei van de winst
65.7%
Groei van de winst per aandeel
| Biotechs Groei van de industrie | 17.0% |
| Inkomstengroei | n/a |
| Rendement op eigen vermogen | -35.7% |
| Nettomarge | n/a |
| Laatste winstupdate | 30 Sep 2022 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Imago BioSciences (NASDAQ:IMGO) Is In A Good Position To Deliver On Growth Plans
Nov 08
Imago BioSciences GAAP EPS of -$0.41 beats by $0.09
Aug 12Here's Why We're Not Too Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Situation
Jul 26Companies Like Imago BioSciences (NASDAQ:IMGO) Are In A Position To Invest In Growth
Apr 12We're Not Very Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Rate
Dec 08Opbrengsten en kosten
Hoe Imago BioSciences geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 22 | 0 | -62 | 16 | 47 |
| 30 Jun 22 | 0 | -57 | 15 | 42 |
| 31 Mar 22 | 0 | -52 | 12 | 40 |
| 31 Dec 21 | 0 | -42 | 10 | 32 |
| 30 Sep 21 | 0 | -33 | 9 | 25 |
| 30 Jun 21 | 0 | -26 | 6 | 20 |
| 31 Mar 21 | 0 | -21 | 5 | 16 |
| 31 Dec 20 | 0 | -18 | 3 | 15 |
Kwaliteitswinsten: IMGO is currently unprofitable.
Groeiende winstmarge: IMGO is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Insufficient data to determine if IMGO's year-on-year earnings growth rate was positive over the past 5 years.
Versnelling van de groei: Unable to compare IMGO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: IMGO is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-42.7%).
Rendement op eigen vermogen
Hoge ROE: IMGO has a negative Return on Equity (-35.71%), as it is currently unprofitable.